SCHEMBL13077005

SCHEMBL13077005

O=C(O)CCCCn1c(NC(=O)c2cccc(NS(=O)(=O)c3ccccc3)c2)nc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK2 P49760 2/20 0.61
▸ CLK4 Q9HAZ1 2/20 0.61
▸ CDK9 P50750 1/20 0.61
▸ MST1R Q04912 1/20 0.61
▸ IRAK4 Q9NWZ3 8/20 0.56
▸ KDM4E B2RXH2 4/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ TSHR P16473 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ USP2 O75604 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ OPRK1 P41145 3/20 0.54
▸ EGFR P00533 2/20 0.53
▸ FGFR1 P11362 2/20 0.53
▸ KDR P35968 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796774 0.94 CLK2 (0.60) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL13077188 0.91 CLK2 (0.59) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL3793594 0.91 CLK2 (0.73) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL3801292 0.88 KDM4E (0.69) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL3809483 0.87 CLK2 (0.57) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL3803908 0.82 KDM4E (0.59) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL3799820 0.81 IRAK4 (0.67) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL13077039 0.80 ITK (0.57) ITK
SCHEMBL13076229 0.80 MAP3K7 (0.66) CLK2CLK4CDK9MST1RIRAK4
SCHEMBL3799346 0.80 MEN1 (0.56) CLK2CLK4CDK9MST1RIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010126922-A1 BENZIMIDAZOLECARBOXAMIDES AS INHIBITORS OF FAK GLAXOSMITHKLINE LLC (US) 2010-11-04 — — WO disclosed
Send feedback